MedPath

Peripheral Intravenous Cannulation Outcome with the use of topical anaesthesia in pediatric emergency department in Japan: A prospective observational study

Phase 3
Conditions
Healthy Children who presented in the ED
Registration Number
JPRN-UMIN000029254
Lead Sponsor
Tokyo Metropolitan Children's Medical Center
Brief Summary

383 patients used topical anesthesia while 96 patients didn't. The success rate of first intravenous catheterization insertion was 77.3% in the topical anesthesia group while placebo group's success rate was 67.7%. The underlying disease, years of experience, the use of LED transilluminator, and the presence of hand motion was adjusted in the comparison analysis. The comparison analysis showed OR 2.0 (95%CI 1.1-3.7) in the topical anesthesia group compared to placebo group.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
520
Inclusion Criteria

Not provided

Exclusion Criteria

1. Evaluated as "blue triage" based on JTAS triage system or similar conditions at the initial encounter. (unstable breathing or circulation in need of emergent intervention) 2. The doctor in charge of the study or the doctors in alliance with the study decide ineligible to participate in the study. 3. Patients or the guardians who were unwilling to participate in the study.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The success rate of peripheral intravenous insertion with the use of lidocaine patch.
Secondary Outcome Measures
NameTimeMethod
1 Success rate between peripheral intravenous insertion with lidocaine patch and without lidocaine patch in the previous trial (UMIN000014730) 2 Duration of lidocaine patch attachment and success rate 3 The pain scale and success rate 4 The pain scale with/without lidocaine patch 5 The pain scale and duration of lidocaine patch attachment 6 Success rate and person's experience as a pediatrician
© Copyright 2025. All Rights Reserved by MedPath